Crypto news: When choosing First Trust’s biotechnology ETF (FBT) and State Street’s broader healthcare ETF (XLV), investors must weigh XLV’s diversified, low-cost broad healthcare exposure against FBT’s concentrated, high-growth biotechnology focus. Both funds provide investment exposure tailored to the healthcare industry, but they differ significantly in scope. XLV tracks the entire S&P 500 healthcare components, while FBT focuses on a specific basket of equally weighted biotechnology companies.
CoinNetwork